You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 142 No. 2, February 1982 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL INVESTIGATIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Immune Responses to Varicella-Zoster in the Aged

Bryan L. Burke, MD; Russell W. Steele, MD; Owen W. Beard, MD; James S. Wood, MD; Thomas D. Cain, MD; Daniel J. Marmer, MS

Arch Intern Med. 1982;142(2):291-293.


Abstract

Skin test reactivity and in vitro lymphocyte stimulation responses to varicella-zoster (VZ) were examined in a large normal population ranging in age from 6 months to 93 years. Waning of cellular immunity, as examined by skin delayed hypersensitivity, began at age 40 years. Skin test responses to phytohemagglutinin, however, remained positive into the eighth decade of life. In vitro lymphocyte stimulation responses to VZ were usually positive (stimulation index ≥ 2.5) until age 60 years, after which time levels, as observed with nonimmune individuals, were often demonstrated. Antibody levels, as measured by fluorescent antibody to membrane antigen, remained positive into the ninth and tenth decades of life. This was especially so with a history of reactivation (zoster) VZ infections, while skin test and in vitro responses were rarely positive in those individuals. Thus cellular, as contrasted with humoral, immunity decreases with advancing age, which may account for a propensity to reactivation of VZ virus.

(Arch Intern Med 1982;142:291-293)



Author Affiliations

From the Section of Geriatrics, Department of Medicine (Drs Beard, Wood, and Cain), and the Section of Immunology and Infectious Diseases, Department of Pediatrics (Drs Burke and Steele and Mr Marmer), University of Arkansas for Medical Sciences (Dr Steele) and Veterans Administration Hospital, Little Rock; and the Division of Microbiology and Immunology, The National Center for Toxicological Research, Jefferson, Ark (Drs Burke and Steele and Mr Marmer).


Footnotes

Accepted for publication June 8, 1981.

Reprint requests to University of Arkansas for Medical Sciences, 4301 W Markham, Slot 512, Little Rock, AR 72205 (Dr Steele).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Herpes Zoster Overview: Natural History and Incidence
Weaver
JAOA: Journal of the American Osteopathic Association 2009;109:S2-S6.
ABSTRACT | FULL TEXT  

Varicella-zoster virus reactivation during acute enterovirus infection is associated with CD8 lymphocytopenia
Chia and Chia
BMJ Case Reports 2009;2009:bcr0820080803-bcr0820080803.
ABSTRACT | FULL TEXT  

Prevention of Varicella: Recommendations for Use of Varicella Vaccines in Children, Including a Recommendation for a Routine 2-Dose Varicella Immunization Schedule
Committee on Infectious Diseases
Pediatrics 2007;120:221-231.
ABSTRACT | FULL TEXT  

Varicella-Zoster Vaccine for the Prevention of Herpes Zoster
Kimberlin and Whitley
NEJM 2007;356:1338-1343.
FULL TEXT  

Herpes Zoster Vaccine: Clinical Trial Evidence and Implications for Medical Practice
Burke
JAOA: Journal of the American Osteopathic Association 2007;107:S14-S18.
ABSTRACT | FULL TEXT  

A Vaccine to Prevent Herpes Zoster and Postherpetic Neuralgia in Older Adults
Oxman et al.
NEJM 2005;352:2271-2284.
ABSTRACT | FULL TEXT  

Preventing Varicella-Zoster Disease
Hambleton and Gershon
Clin. Microbiol. Rev. 2005;18:70-80.
ABSTRACT | FULL TEXT  

Shingles Immunity and Health Functioning in the Elderly: Tai Chi Chih as a Behavioral Treatment
Irwin et al.
Evid Based Complement Alternat Med 2004;1:223-232.
ABSTRACT | FULL TEXT  

Case-control study of the effect of mechanical trauma on the risk of herpes zoster
Thomas et al.
BMJ 2004;328:439.
FULL TEXT  

Vaccination to prevent varicella and shingles
Breuer
J. Clin. Pathol. 2001;54:743-747.
ABSTRACT | FULL TEXT  

Postherpetic Neuralgia -- Pathogenesis, Treatment, and Prevention
Kost and Straus
NEJM 1996;335:32-42.
FULL TEXT  

Effect of Hypnotic Suggestion on the Delayed-Type Hypersensitivity Response
Locke et al.
JAMA 1994;272:47-52.
ABSTRACT  

Ocular Varicella-Zoster Virus Infection in the Guinea Pig: A New In Vivo Model
Pavan-Langston and Dunkel
Arch Ophthalmol 1989;107:1068-1072.
ABSTRACT  

Varicella-Zoster Virus Infections: Biology, Natural History, Treatment, and Prevention
STRAUS et al.
ANN INTERN MED 1988;108:221-237.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1982 American Medical Association. All Rights Reserved.